ELANCO AH0351 OESTRADIOL COMPUDOSE 100 Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco ah0351 oestradiol compudose 100

elanco australasia pty ltd - oestradiol 17 beta - parenteral implant, device - oestradiol 17 beta steroid-estrogen active 21.1 mg/do - nutrition & metabolism - heifer (young female cattle) | heifer speyed (neutered young cow) | steer (castrated male cattle) | beef | bovine | bullock (you - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

CERIANNA- fluoroestradiol f 18 injection United States - English - NLM (National Library of Medicine)

cerianna- fluoroestradiol f 18 injection

ge healthcare inc. - fluoroestradiol f-18 (unii: t32277kb09) (fluoroestradiol f-18 - unii:t32277kb09) - cerianna is indicated for use with positron emission tomography (pet) imaging for the detection of estrogen receptor (er)-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer. limitations of use tissue biopsy should be used to confirm recurrence of breast cancer and to verify er status by pathology. cerianna is not useful for imaging other receptors, such as human epidermal growth factor receptor 2 (her2) and the progesterone receptor (pr). none. risk summary all radiopharmaceuticals, including cerianna, have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of radiation dose. advise a pregnant woman of the potential risks of fetal exposure to radiation from administration of cerianna. there are no available data on cerianna use in pregnant women. no animal reproduction studies using fluoroestradiol f 18 have been conducted to evaluate its effect on female reproduction and embryo-fetal development. the estimated background risk of major birth defects and miscarriage for the indicated populations is unknown. all pregnancies have a background risk of birth defects, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary there are no data on the presence of fluoroestradiol f 18 in human milk, or its effects on the breastfed infant or milk production. lactation studies have not been conducted in animals. advise a lactating woman to avoid breastfeeding for 4 hours after cerianna administration in order to minimize radiation exposure to a breastfed infant. the safety and effectiveness of cerianna in pediatric patients have not been established. clinical studies of fluoroestradiol f 18 injection did not reveal any difference in pharmacokinetics or biodistribution in patients aged 65 and over.

ELANCO AH 0343 OESTRADIOL COMPUDOSE 400 Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco ah 0343 oestradiol compudose 400

elanco australasia pty ltd - oestradiol 17 beta - parenteral implant, device - oestradiol 17 beta steroid-estrogen active 43.9 mg/do - nutrition & metabolism - heifer (vealer) | heifer speyed (neutered young cow) | steer (castrated male cattle) | beef | bovine | bullock (young) | male ca - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

ELANCO AH 0323 OESTRADIOL COMPUDOSE 200 Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco ah 0323 oestradiol compudose 200

elanco australasia pty ltd - oestradiol 17 beta - parenteral implant, device - oestradiol 17 beta steroid-estrogen active 25.7 mg/do - nutrition & metabolism - heifer (vealer) | heifer speyed (neutered young cow) | steer (castrated male cattle) | beef | bovine | bullock (young) | male ca - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

BOMEROL 1MG/ML OESTRADIOL BENZOATE INJECTION Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bomerol 1mg/ml oestradiol benzoate injection

elanco australasia pty ltd - oestradiol benzoate - parenteral liquid/solution/suspension - oestradiol benzoate steroid-estrogen active 1.0 mg/ml - endocrine system - cattle - adult | heifer | bovine - fertility problems | stimulate ovulation | anoestrus | oestrus cycle | ovarian cysts | promote ovulation | superovulation

oestradiol benzoate Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

oestradiol benzoate

syntex s.a. - oestradiol benzoate - unknown - oestradiol benzoate steroid-estrogen active 0.0 - active constituent

OESTRADIOL Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

oestradiol

elanco australasia pty ltd - oestradiol - unknown - oestradiol steroid-estrogen active 0.0 - active constituent

Drospirenone/ ethinyloestradiol-gh Australia - English - Department of Health (Therapeutic Goods Administration)

drospirenone/ ethinyloestradiol-gh

lupin australia pty limited - drospirenone; ethinylestradiol; ethinyloestradiol -

Drospirenone/ ethinyloestradiol-lupin Australia - English - Department of Health (Therapeutic Goods Administration)

drospirenone/ ethinyloestradiol-lupin

lupin australia pty limited - drospirenone; ethinylestradiol; ethinyloestradiol -